Experimental approaches to determining the choice of first-step therapy for patients with hypertension

Clinical and Experimental Hypertension

Volumn 18, Issue 3-4, 1996, Pages 569-579

  Whelton, Paul K ^a,b,c   Williamson, Jeff D ^a,c   Louis, Gail T ^a,b   Davis, Barry R ^d   Cutler, Jeffrey A ^e  

^a DEPARTMENT OF PATHOLOGY   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

^e NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

cardiovascular disease; clinical trials; epidemiology; high blood pressure; hypertension; pharmacology; prevention

Indexed keywords

EID: 0029960977     PISSN: 10641963     EISSN: None     Source Type: Journal    
DOI: 10.3109/10641969609088986     Document Type: Conference Paper

References (17)

1. World Health Statistics Annual, 1992. World Health Organization, Geneva, 1992.
2. Whelton PK, Brancati F, Appel LJ, Klag MJ. The challenge of hypertension and atherosclerotic cardiovascular disease in economically developing countries. High Blood Pressure and Cardiovascular Prevention. 1995;4:36-45.
3. Whelton PK. Epidemiology of hypertension. Lancet. 1994;344:101-106.
4. Stamler J, Stamler R, Neaton JD. Blood pressure, systolic and diastolic, and cardiovascular risks: U.S. population data. Arch Intern Med. 1993;153:598-615.
5. Whelton PK, He J, Klag MJ. Blood pressure in westernized populations. In: Swales JD, ed. Textbook of Hypertension. Blackwell Scientific Publications, Ltd., Oxford, 1994:11-21.
6. Ibrahim MM, Rizk H, Appel LJ, Aroussy WE, Helmy S, Sharaf Y, Ashour Z, Kandil H, Roccella E, Whelton PK, for the National Hypertension Project Investigative Team. Hypertension prevalence, awareness, treatment and control in Egypt: results from the Egyptian National Hypertension Project (NHP). Hypertension. In press.
7. Collins R, Peto R, MacMahon S, et al. Blood pressure, stroke, and coronary heart disease. Part 2, short-term reductions in blood pressure: overview of randomized drug trials in their epidemiologic context. Lancet. 1990;335:765-774.
8. Hebert P, Moser M, Mayer J, Glynn RJ, Hennekens CH. Recent evidence of drug therapy of mild to moderate hypertension and decreased risk of coronary heart disease. Arch Intern Med. 1993;153:578-581.
9. Manolio TA, Cutler JA, Furberg CD, Psaty BM, Whelton PK, Applegate WB. Trends in pharmacologic management of hypertension in the United States. Arch Intern Med. 1995;155:829-837.
10. Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. The Fifth Report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure (JNC V). Arch Intern Med. 1993;153:154-183.
11. Held PH, Yusuf S, Furberg CD. Calcium channel blockers in acute myocardial infarction and unstable angina: an overview. Br Med J. 1989;299:1187-1192.
12. Yusuf S, Held P, Furberg C. Update of effects of calcium antagonists in myocardial infarction or angina in light of the second Danish Verapamil Infarction Trial (DAVIT-II). Am J Cardiol. 1991;67:1295-1297.
13. Psaty BM, Heckbert SR, Koepsell TD, Siscovick DS, Lemaitre R, Smith NL, Wahl PW, Wagner EH, Furberg CD. The risk of incident myocardial infarction associated with anti-hypertensive therapies. Circulation. 1995;91:18 (Abstract).
14. Neaton JD, Grimm RH, Prineas RJ, Stamler J, Grandits GA, Elmer PJ, Cutler JA, Flack JM, Schoenberger JA, McDonald R, Lewis CE, Liebson PR, for the Treatment of Mild Hypertension Study Research Group. Treatment of Mild Hypertension Study. Final results. JAMA. 1993;270:713-724.
15. Materson BJ, Reda DJ, Cushman WC, Massie BM, Freis ED, Kochar MS, Hamburger RJ, Fye C, Lakshman R, Gottdiener J, Ramirez EA, Henderson WG, for the Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents. Single-drug therapy for hypertension in men. A comparison of six antihypertensive agents with placebo. N Engl J Med. 1993;328:914-921.
16. Davis BR, Cutler JA, Gordon DJ, Furberg CD, Wright C, Cushman WC, Grimm RH, LaRosa J, Whelton PK, Perry HM, Alderman MH, Ford CE, Oparil S, Francis C, Proschan M, Pressel S, Black HR, Hawkins CM, for the ALLHAT Research Group. Rationale and design for the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). Am J Hypertens. In press.
17. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II). JAMA. 1993;269:3015-3023.